Skip to main content
Clinical Trials/NCT00948051
NCT00948051CompletedNot Applicable

A Placebo-controlled, Double-blind Randomized Study to Evaluate the Efficacy of a follow-on Milk Formula Supplemented With Fructo-oligosaccharides on Immune Response in Healthy Infants

Syral1 site in 1 country60 target enrollmentStarted: March 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To evaluate the impact of the intake of a follow-on milk formula supplemented with FOS in increasing infant's response to vaccination

Study Overview

Brief Summary

In this study the investigators hypothesized that the chronic intake of fructo-oligosaccharides would increase fecal immunoglobulin A (IgA) specific to poliovirus vaccination and bifidobacteria in infants.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
4 Months to 5 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • infants aged of 4 months at randomization
  • not breast-fed infants

Exclusion Criteria

  • infants suffering from a chronic or severe disease susceptible to interfere with one of the evaluation criteria
  • infants suffering from a disease associated with gastro-intestinal disorder
  • infants who have taken antibiotic during the 2 months preceding randomization

Outcomes

Primary Outcomes

To evaluate the impact of the intake of a follow-on milk formula supplemented with FOS in increasing infant's response to vaccination

Time Frame: 1 month

Secondary Outcomes

  • To evaluate the impact of the intake of a follow-on milk formula supplemented with FOS in increasing infant's faecal bifidobacteria concentration(1 month)

Investigators

Sponsor
Syral
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Effects of follow-on Formula Enriched on... | Clinical Trial